WireSift
← AI Adoption Tracker
WireSift Research · AI Adoption Tracker · Q1 2026

UNHUnitedHealth Group Incorporated

AI adoption · Q1 2026 earnings call

Health CareScaling
AI mentions
23
extracted from this call
Max specificity
5 / 5
financialized — dollar / segment level
AI revenue
Not disclosed
no breakout in this call
UnitedHealth Group disclosed a $1.5 billion AI investment plan for 2026, framing AI as central to both internal productivity transformation and external product commercialization through Optum Insight. Management provided specific metrics on several AI-enabled products including Avery (generative AI chatbot targeting 20M members), Optum Real (0.5B transactions YTD, targeting 2.5B by year-end), and PreCheck Prior Authorization (approval time reduced from 8+ hours to under 30 seconds). The company expects a 2:1 return on internal AI investments over the next few years, with many programs paying back within 12-18 months, though management declined to provide specific P&L guidance on AI's contribution to long-term margin targets.
Public Company AI Adoption Index
Adopter
See full leaderboard →
Composite
71/ 100
#20 non-tech · #60 overall · #2 in Health Care
Depth · 40%
80
stage: scaling · max spec: 5
Disclosure · 40%
55
4 quant outcomes
Breadth · 20%
85
3 scopes
Adoption scopes:internal_useproduct_embeddedproduct_standalone
Every claim, sourced

23 AI mentions from this call.

Extracted verbatim from the UNH Q1 2026 earnings call transcript. Speaker, section, and specificity tier surfaced for each mention.

  • T5Q&A· Other· Internal use
    Analyst questionparaphrased· Mizuho Securities· Ann Hynes
    Can you share some maybe targets you have on how you think AI will -- from the cost side, maybe like SG&A, do you have a target internally, how you think it could save? And then just also on the revenue side with Optum Insight, do you think your investment in AI could like structurally shift the growth rate of that segment?
    As we said earlier, we are spending about $1.5 billion in AI across UnitedHealth Group. Think about it this way, 1/3 of this is explicitly invested into software products and platform, accelerating Optum Insight's transition of business models into an AI-first software and services firm. The remaining 2/3 is spent across signature end-to-end processes and functions across UnitedHealth Group.
    Sandeep Dadlani, UNH earnings call
  • T5Prepared remarks· CEO· Internal use
    We remain on track to invest nearly $1.5 billion in AI-related initiatives in 2026.
    Stephen Hemsley, UNH earnings call
  • T4Q&A· Other· Standalone AI product
    Analyst questionparaphrased· Mizuho Securities· Ann Hynes
    Can you share some maybe targets you have on how you think AI will -- from the cost side, maybe like SG&A, do you have a target internally, how you think it could save?
    this quarter, we launched digital prior auth in keeping with the enterprise priority on prior auths. We already have a couple of payer clients and provider clients using them, another 50 clients in the pipeline. And the early results are that prior auths submitted through our software have shown a 96% approval rate on first submissions.
    Sandeep Dadlani, UNH earnings call
    Productsdigital prior auth
  • T4Q&A· Other· Internal use
    Analyst questionparaphrased· Mizuho Securities· Ann Hynes
    Can you share some maybe targets you have on how you think AI will -- from the cost side, maybe like SG&A, do you have a target internally, how you think it could save?
    In the end, all internal investments in AI use cases is routed through Optum Insight and has the potential to be commercialized outside of UHG, and we expect a return conservatively of 2:1 on these programs over the next few years, many of them paying back within the next 12 to 18 months.
    Sandeep Dadlani, UNH earnings call
  • T4Prepared remarks· Other· Product-embedded AI
    Member adoption of UHC AI-powered digital tools continues to grow. Almost half of all members are now registered for and using UHC digital access. We saw 73 million digital visits in Q1, up 42% over the last 2 years, reflecting sustained and growing engagement with our digital platform.
    Timothy Noel, UNH earnings call
    ProductsUHC digital access
  • T4Prepared remarks· Other· Standalone AI product
    Our unique PreCheck Prior Authorization capability reduces prescription approval time from over 8 hours to under 30 seconds and provides a 68% reduction in denial due to missing information and an 88% reduction in appeals, easing interactions for clients, members and providers.
    Patrick Conway, UNH earnings call
    ProductsPreCheck Prior Authorization
  • T4Prepared remarks· Other· Standalone AI product
    At Optum Insight, new AI-first products continue to gain traction. Optum Real is helping payers and care providers deal more efficiently with administrative functions such as claim adjudication and coverage validation and can reduce manual contact costs by 76%.
    Patrick Conway, UNH earnings call
    ProductsOptum Real
  • T4Q&A· Other· Standalone AI product
    Analyst questionparaphrased· Mizuho Securities· Ann Hynes
    Can you share some maybe targets you have on how you think AI will -- from the cost side, maybe like SG&A, do you have a target internally, how you think it could save?
    Areas like consumer member experience. You must have noticed we just launched Avery, a generative AI chatbot answering member questions for UnitedHealthcare, which will be expanded to over 20 million members by the year-end.
    Sandeep Dadlani, UNH earnings call
    ProductsAvery
  • T4Prepared remarks· Other· Standalone AI product
    We started the year by onboarding more than 800 new clients while reducing contact call center volume 25% through enhanced digital and AI-enabled self-service with member satisfaction over 95%.
    Patrick Conway, UNH earnings call
  • T4Q&A· Other· Standalone AI product
    Analyst questionparaphrased· Mizuho Securities· Ann Hynes
    Can you share some maybe targets you have on how you think AI will -- from the cost side, maybe like SG&A, do you have a target internally, how you think it could save?
    Optum Real, an AI-first platform launched a couple of quarters ago, now has 0.5 billion transactions year-to-date and expects to close the year at over 2.5 billion transactions.
    Sandeep Dadlani, UNH earnings call
    ProductsOptum Real
  • T4Prepared remarks· Other· Product-embedded AI
    Digital self-service is now the primary way members interact with us, with over 80% of consumer contacts through digital formats and an NPS in the top quartile of the industry.
    Timothy Noel, UNH earnings call
  • T4Prepared remarks· Other· Product-embedded AI
    For care providers, digital channels continue to grow, with transaction volumes up 75% year-over-year and about 75% of in-network providers using our portal or API tools.
    Timothy Noel, UNH earnings call
  • T3Q&A· CFO· Standalone AI product
    Analyst questionparaphrased· JPMorgan· Lisa Gill
    Optum Insight and Optum Rx really being back half weighted. It seems like that's a little bit higher than it's been historically. So is there anything to think about there?
    for Optum Insight, I would view this as what we're doing is a couple of things. One is slowly decommissioning old products that were not AI-based and reinvesting in those products through the AI investments. So you're getting the slow rundown of those products in Q1 and then the investments to transfer those over into more AI-based. And I think you'll see the benefits of that coming into the back half.
    Wayne DeVeydt, UNH earnings call
  • T3Prepared remarks· Other· Product-embedded AI
    We are rapidly scaling self-service digital scheduling, including AI-enabled tools that guide patients to the right appointment in the right setting at the right time for them. That's improving access, reducing friction and expanding capacity without adding incremental clinical burden.
    Patrick Conway, UNH earnings call
  • T3Q&A· Other· Internal use
    Analyst questionparaphrased· Mizuho Securities· Ann Hynes
    Can you share some maybe targets you have on how you think AI will -- from the cost side, maybe like SG&A, do you have a target internally, how you think it could save?
    A third area is clinical workflows. For example, Ambient rollout for physicians and nurses in Optum Health and then summarization capabilities for nurses and clinical reviews.
    Sandeep Dadlani, UNH earnings call
    ProductsAmbient
  • T3Q&A· Other· Standalone AI product
    Analyst questionparaphrased· Mizuho Securities· Ann Hynes
    Can you share some maybe targets you have on how you think AI will -- from the cost side, maybe like SG&A, do you have a target internally, how you think it could save?
    Optum AI, our new AI consulting arm, has already signed its first few contracts, helping companies like LabCorp through their operational AI initiatives.
    Sandeep Dadlani, UNH earnings call
    ProductsOptum AI
  • T2Prepared remarks· CEO· Internal use
    Our enterprise-wide AI ambitions are meaningful and the agenda is in motion. We're getting after business units and functions alike and, importantly, critical processes that are core to several of our businesses. This is not just a matter of being more productive at what we already do, but a reimagining of how we organize, operate and work going forward.
    Stephen Hemsley, UNH earnings call
  • T2Prepared remarks· CEO· Standalone AI product
    Optum Insight has untapped potential in an AI-centric world. They're starting to sell business and building broader service relationships around that reality, but to evolve more modern scale solutions and for users to be ready to embrace them will take more time, in my mind, later into 2026 and into 2027.
    Stephen Hemsley, UNH earnings call
  • T2Q&A· CFO· Internal use
    Analyst questionparaphrased· JPMorgan· Lisa Gill
    Optum Insight and Optum Rx really being back half weighted.
    I would also just remind you that we've assumed a little bit of lower script volume, obviously, due to the membership that we had. But as the year progresses, I think you'll see some of our G&A initiatives and AI investments coming through, and that will actually improve the outlook in the back half.
    Wayne DeVeydt, UNH earnings call
  • T2Prepared remarks· CFO· Internal use
    The operating cost ratio was 13.8% in the quarter, reflecting the timing of targeted investments across operations, technology and care delivery as well as incremental investments in areas such as AI, customer experience, cybersecurity and community engagement.
    Wayne DeVeydt, UNH earnings call
  • T2Prepared remarks· CEO· Internal use
    We are investing in AI-enabled modernization. While early, these capabilities are already improving experiences for consumers and care providers, increasing productivity and reducing administrative burden.
    Stephen Hemsley, UNH earnings call
  • T2Prepared remarks· CEO· Standalone AI product
    Optum Insight is seeing increased market interest with its AI-first enterprise approach.
    Stephen Hemsley, UNH earnings call
  • T1Q&A· CEO· Internal use
    Analyst questionparaphrased· Morgan Stanley· Erin Wilson Wright
    What should we, though, expect in terms of these savings accelerating in 2027, '28? I guess, should we anticipate that the cost and contributions or how do we weigh the cost and then contributions of some of the efficiency gains there?
    This is kind of uncharted territory when you think about the scope that this could have. So we aren't giving any guidance with respect to the compounding effect, if you will, of these kinds of changes across the business.
    Stephen Hemsley, UNH earnings call
Q&A Dynamics

What management wouldn’t quantify.

Analyst questions where management declined to share a specific number. The pattern of refusals is often as informative as the disclosures.

  1. Management declined to provide specific guidance on AI's contribution to long-term margin targets despite direct analyst questions from Mizuho (Ann Hynes) and Morgan Stanley (Erin Wright). CEO stated it would be 'very premature to offer guidance in terms of what the impact of those could be.'
  2. No breakdown of AI revenue contribution from Optum Insight's AI-first products was disclosed; only transaction volume and pipeline metrics were provided.
  3. The 2:1 return expectation on internal AI investments was stated without specifying the baseline investment amount, time period, or measurement methodology.
  4. No quantification of headcount impact or FTE savings from AI automation was provided.
  5. Avery chatbot member satisfaction or NPS metrics were not disclosed.
Stay informed

Independent research, direct to your inbox.

Live data tracking and analysis. Deep research that cuts through consensus. Evidence-backed insights.

By subscribing, you agree to our Privacy Policy.

Sourced from primary documents · See the methodology for the extraction approach.